Orange Book product · Brand (NDA)
PROQUIN XR
CIPROFLOXACIN HYDROCHLORIDE
At a glance
May 19, 2005
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 19, 2005
21 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
CIPROFLOXACIN HYDROCHLORIDE
Strength
EQ 500MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 021744
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2009CETRAXALBrand (NDA)
NDA 021918 · LAB SALVAT
- 1998CILOXANBrand (NDA)
NDA 020369 · SANDOZ
- 1990CILOXANBrand (NDA)
NDA 019992 · SANDOZ
- 1987CIPROBrand (NDA)
NDA 019537 · BAYER HLTHCARE
- 2024CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 217887 · ALEMBIC THERAP
- 2018CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 208921 · YILING
- 2018CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 204613 · ALTAIRE PHARMS INC
- 2008CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 076555 · PHARMOBEDIENT
- 2008CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 077568 · FDC LTD
- 2008CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 078598 · AMRING PHARMS
- 2007CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 077859 · AUROBINDO PHARMA
- 2006CIPROFLOXACIN HYDROCHLORIDEGeneric (ANDA)
ANDA 077689 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
